Incannex Healthcare Halted, News Pending
Freshpet Inc (NASDAQ:FRPT) stock has reached a new 52-week low, touching 70.62 USD, with a market capitalization of $3.45 billion. According to InvestingPro analysis, the stock appears undervalued at current levels, with a beta of 1.86 indicating higher volatility than the market. This marks a significant downturn for the company, as it reflects a one-year change of -44.67%. Despite the price decline, Freshpet has maintained strong revenue growth of 23.24% and trades at a P/E ratio of 222.44. The decline in Freshpet’s stock price over the past year highlights challenges the company may be facing in maintaining investor confidence and market stability. The recent dip to this 52-week low could prompt further scrutiny from analysts and investors alike, as they assess the factors contributing to this downward trend. InvestingPro subscribers can access 13 additional key insights and a comprehensive Pro Research Report for deeper analysis of FRPT’s current position and future potential.
In other recent news, Freshpet reported first-quarter 2025 results, showing an 18% year-over-year revenue increase to $263 million, slightly surpassing consensus expectations. The company achieved a 45.7% adjusted gross margin, marking a 40 basis points improvement from the previous year. Freshpet’s adjusted earnings per share were $0.08, just below the consensus of $0.10, while adjusted EBITDA reached $35.5 million, exceeding the forecasted $34.1 million. Despite these achievements, UBS initiated coverage with a sell rating, citing concerns about overly optimistic growth expectations and predicting more modest growth in the near term. In contrast, Stifel resumed coverage with a buy rating, recognizing current challenges but highlighting long-term growth potential. TD Cowen downgraded the stock to Hold, setting a price target of $96 due to concerns over slowing retail sales growth. Benchmark maintained a Buy rating but lowered its price target to $120, reflecting revised fiscal guidance. Freshpet’s updated sales guidance for 2025 anticipates growth between 15% and 18%, acknowledging current slower growth trends.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.